Cardio Diagnostics Holdings (CDIO) Asset Utilization Ratio (2022 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Asset Utilization Ratio of 0.0 for Q1 2026, up 6.77% sequentially from 0.0 in Q4 2025, and up 10.0% YoY from 0.0 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.0 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 10.0% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (up 10.0% YoY) and the FY2025 annual result came in at 0.0, down 65.15% from the prior year.
- Asset Utilization Ratio grew to 0.0 in Q1 2026 per CDIO's latest filing, from 0.0 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.01 in Q2 2024 and troughed at 0.0 in Q4 2022.
- A 5-year average of 0.0 and a median of 0.0 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 12314.18% in 2023, then slumped 81.71% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2022, then surged by 12314.18% to 0.0 in 2023, then surged by 41.19% to 0.0 in 2024, then sank by 61.25% to 0.0 in 2025, then climbed by 6.77% to 0.0 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Cardio Diagnostics Holdings | 6.42 Mn | 835,350.96 | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |